Home / Stocks / ACTU

ACTU insider trading

ACTUATE THERAPEUTICS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$1.5M
Buys · last 90 days
0 · $0
Most recent buy
2025-06-30

Cluster buy detected

3 insiders bought ACTU within a short window (2025-06-27), $1.5M in total — cluster score 22/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-07Kairos Venture Partners II, L.P.
Director · 10% owner
Sold280,000$5.80$1.6M
2025-06-30BP Directors, LPcluster
Director · 10% owner
Bought71,428$7.00$500k
2025-06-30BIOS Fund I QP, LPcluster
Director · 10% owner
Bought71,428$7.00$500k
2025-06-30BIOS Actuate Co-Invest I, LPcluster
Director · 10% owner
Bought71,428$7.00$500k

Most active insider buyers

InsiderRoleBuysTotal bought
BP Directors, LPDirector · 10% owner1$500k
BIOS Fund I QP, LPDirector · 10% owner1$500k
BIOS Actuate Co-Invest I, LPDirector · 10% owner1$500k

See ACTU on the chart

Every insider buy and sell for ACTU plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.